Tianyang Gao

Tianyang Gao

Auto-generated profile, based on publicly available information

Tianyang Gao

Institute of Orthopaedics, Chinese PLA General Hospital, Beijing Key Lab of Regenerative Medicine in Orthopaedics, Key Laboratory of Musculoskeletal Trauma & War Injuries, 28 Fuxing Road, Haidian District, Beijing 100853, China; Shanxi Medical University, No. 56 XinJiannan Road, YingZe District, Taiyuan 030001, China

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2016 in BioMed Research International
Verified
Journal Article
Open access
PDF file
TGTianyang Gao
Tianyang Gao
WGWeimin Guo
Weimin Guo
MCMingxue Chen
Mingxue Chen
JHJingxiang Huang
Jingxiang Huang
ZYZhiguo Yuan
Zhiguo Yuan
QGQuanyi Guo
Quanyi Guo
Osteoarthritis (OA) is a type of chronic joint disease that is characterized by the degeneration and loss of articular cartilage and hyperplasia of the synovium and subchondral bone. There is reasonable knowledge about articular cartilage physiology, biochemistry, and chondrocyte metabolism. However, the etiology and pathogenesis of OA remain unclear and need urgent clarification to guide the early diagnosis and treatment of OA. Extracellular vesicles (EVs) are small membrane-linking particles that are released from cells. In recent decades, several special biological properties have been found in EV, especially in terms of cartilage. Autophagy plays a critical role in the regulation of cellular homeostasis. Likewise, more and more research has gradually focused on the effect of autophagy on chondrocyte proliferation and function in OA. The synthesis and release of EV are closely associated with autophagy. At the same time, both EV and autophagy play a role in OA development. Based on the mechanism of EV and autophagy in OA development, EV may be beneficial in the early diagnosis of OA; on the other hand, the combination of EV and autophagy-related regulatory drugs may provide insight into possible OA therapeutic strategies.